Bayesian Capital Management, LP Astrazeneca PLC Transaction History

Bayesian Capital Management, LP

$838 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $1.57 Million - $1.9 Million	23,500 Added 691.18%	26,900 $2.1 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $408,901 - $466,118	-6,700 Reduced 66.34%	3,400 $230,000
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $476,553 - $533,456	-7,700 Reduced 43.26%	10,100 $680,000
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $2.11 Million - $2.33 Million	-32,500 Reduced 64.61%	17,800 $1.21 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $617,235 - $669,326	8,829 Added 21.29%	50,300 $3.6 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $2.62 Million - $2.97 Million	41,471 New	41,471 $2.88 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $1.83 Million - $2.2 Million	-30,939 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $938,269 - $1.13 Million	16,839 Added 119.43%	30,939 $2.05 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $831,908 - $982,982	-15,400 Reduced 52.2%	14,100 $821,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $1.64 Million - $1.79 Million	29,500 New	29,500 $1.77 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $875,495 - $1.01 Million	-16,497 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $458,627 - $588,553	10,641 Added 181.71%	16,497 $873,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $1.74 Million - $2.36 Million	-46,000 Reduced 88.71%	5,856 $262,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $2.2 Million - $2.62 Million	51,856 New	51,856 $2.59 Million
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $712,370 - $807,365	-17,756 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $1.83 Million - $2.05 Million	-49,200 Reduced 73.48%	17,756 $733,000
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $1.27 Million - $1.54 Million	35,743 Added 114.51%	66,956 $2.71 Million
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $1.15 Million - $1.3 Million	31,213 New	31,213 $1.19 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account